Bioceres | Bioceres S.A. Postpones Initial Public Offering of American Depositary Shares

Bioceres S.A. Postpones Initial Public Offering of American Depositary Shares

8 February, 2018

Rosario, Argentina, February 8, 2018 – Bioceres S.A. announced today that due to volatile market conditions it has postponed its initial public offering. Subject to market conditions, the company expects to resume the initial public offering process.

The registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification of these securities under the securities laws of any such state or jurisdiction.

About Bioceres S.A.:

Bioceres S.A. is a fully-integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants and micro-beaded fertilizers. Bioceres’s headquarters and primary operations are based in Argentina, which is its key end-market as well as one of the largest markets globally for genetically modified crops.

For investor and media inquiries, please contact:

Carlos Camargo de Colón

Director of Business Development and Investor Relations

Tel: +(54) 341 486 1100

Email: [email protected]